Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.

about

Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.

Item

http://www.wikidata.org/entity/Q40039995

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.

@en

type

Item

label

Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.

@en

prefLabel

Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.

@en

P1476

Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.

@en

P2093

Elizabeth White

http://www.w3.org/2001/XMLSchema#string

Robert W Shafer

http://www.w3.org/2001/XMLSchema#string

Sergei L Kosakovsky Pond

http://www.w3.org/2001/XMLSchema#string

Soo-Yon Rhee

http://www.w3.org/2001/XMLSchema#string

Thorsteinn Rögnvaldsson

http://www.w3.org/2001/XMLSchema#string

Vici Varghese

http://www.w3.org/2001/XMLSchema#string

W Jeffrey Fessel

http://www.w3.org/2001/XMLSchema#string

P2860

Not so different after all: a comparison of methods for detecting amino acid sites under selection

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites

A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism

Modeling HIV-1 drug resistance as episodic directional selection

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens

HyPhy: hypothesis testing using phylogenies

Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

P2888

s41598-017-11893-8

P304

11559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-11893-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091665757

http://www.w3.org/2001/XMLSchema#string

P698

28912582

http://www.w3.org/2001/XMLSchema#string

P932

5599673

http://www.w3.org/2001/XMLSchema#string